Half-life of Apixaban During Massive Apixaban Overdose

Abstract

Keywords

apixaban half-life overdose

Get full access to this article

View all access options for this article.

References

Harmouche

Stueve

Howland

, et al. Massive apixaban overdose confirmed with blood concentrations and managed without bleeding: A single case report. J Pharm Pract. 2023;12:8971900231177570. doi: 10.1177/08971900231177570.

Zheng

Dai

, et al. Discovery and development of factor Xa inhibitors (2015-2022). Front Pharmacol. 2023. Online ahead of print. doi:10.3389/fphar.2023.1105880.

Scutt

Allen

Waxman

. Estimating a drug’s elimination rate-constant or half-life from a single blood sample: A practical approach with particular benefits for critically ill/vulnerable patients. Biosystems. 2019. Online ahead of print. doi:10.1016/j.biosystems.2019.103996.

Frost

Nepal

Wang

, et al. Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. Br J Clin Pharmacol. 2013;76:776-786.

Franck

Dulaurent

El Balkhi

, et al. Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report. Br J Clin Pharmacol. 2019;85:270-272.